-
Patent Agency Ranking
公开(公告)号：US20240002406A1
公开(公告)日：2024-01-04
申请号：US18339362
申请日：2023-06-22
Applicant: Insilico Medicine IP Limited
IPC: C07D519/00 , C07D471/04
CPC classification number: C07D519/00 , C07D471/04
Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
-
公开(公告)号：US20240067661A1
公开(公告)日：2024-02-29
申请号：US18240886
申请日：2023-08-31
Applicant: Insilico Medicine IP Limited
IPC: C07D519/00 , C07D471/04
CPC classification number: C07D519/00 , C07D471/04
Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
-
公开(公告)号：US20250034132A1
公开(公告)日：2025-01-30
申请号：US18704366
申请日：2022-10-28
Applicant: Insilico Medicine IP Limited
IPC: C07D471/04 , A61K31/4375 , A61K31/444 , A61K31/496 , A61K31/497 , A61K31/5377
Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
-
公开(公告)号：US20230192723A1
公开(公告)日：2023-06-22
申请号：US18110261
申请日：2023-02-15
Applicant: Insilico Medicine IP Limited
IPC: C07D519/00 , C07D471/04
CPC classification number: C07D519/00 , C07D471/04
Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
-
公开(公告)号：US20230192688A1
公开(公告)日：2023-06-22
申请号：US18110259
申请日：2023-02-15
Applicant: Insilico Medicine IP Limited
IPC: C07D471/04
CPC classification number: C07D471/04
Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
-
-
-
-
Search Results
5
records
(took 0.016 seconds)
